Cancer Research Cancer Epigenetics Protein Translation and Cancer
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bhowmick, D. A.
Right arrow Articles by Weil, R. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bhowmick, D. A.
Right arrow Articles by Weil, R. J.
[Cancer Research 64, 1220-1223, February 15, 2004]
© 2004 American Association for Cancer Research

Advances in Brief

A Functional Polymorphism in the EGF Gene Is Found with Increased Frequency in Glioblastoma Multiforme Patients and Is Associated with More Aggressive Disease

Deb A. Bhowmick1,2, Zhengping Zhuang1, Scott D. Wait1 and Robert J. Weil1

1 Surgical Neurology Branch, National Institutes of Neurological Disorders and Stroke, NIH, Bethesda, Maryland, and 2 Baylor College of Medicine, Houston, Texas

Glioblastoma multiforme, the most aggressive form of primary brain tumor in adults, is nearly universally fatal, with 5-year survivals of <5% (P. Kleihues and W. K. Cavenee, eds., pp. 1–314, Lyon: IARC, 2000). Alterations in the epidermal growth factor receptor (EGFR) are common events in many glioblastoma. We hypothesized that a polymorphism in the 5'-untranslated region of the epidermal growth factor (EGF) gene, a natural ligand of the EGFR, may play a role in the genesis of these malignant gliomas. We find that patients with the GA or GG genotype have higher tumoral levels of EGF, irrespective of EGFR status, that they are more likely to recur after surgery, and that they have a statistically significant shorter overall progression-free survival than patients with the AA genotype. These findings suggest that a single nucleotide polymorphism in EGF may play a role in the formation of glioblastomas, is a useful and powerful prognostic marker for these patients, and may be a target for tumor therapy.




This article has been cited by other articles:


Home page
 Ann OncolHome page
K.-L. G. Spindler, R. F. Andersen, L. H. Jensen, J. Ploen, and A. Jakobsen
EGF61A>G polymorphism as predictive marker of clinical outcome to first-line capecitabine and oxaliplatin in metastatic colorectal cancer
Ann. Onc., October 22, 2009; (2009) mdp336v1.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
W. Y. Cheung, R. Zhai, M. H. Kulke, R. S. Heist, K. Asomaning, C. Ma, Z. Wang, L. Su, M. Lanuti, K. K. Tanabe, et al.
Epidermal growth factor A61G gene polymorphism, gastroesophageal reflux disease and esophageal adenocarcinoma risk
Carcinogenesis, August 1, 2009; 30(8): 1363 - 1367.
[Abstract] [Full Text] [PDF]

Home page
 Ann OncolHome page
K. -L. Garm Spindler, N. Pallisgaard, A. A. Rasmussen, J. Lindebjerg, R. F. Andersen, D. Cruger, and A. Jakobsen
The importance of KRAS mutations and EGF61A>G polymorphism to the effect of cetuximab and irinotecan in metastatic colorectal cancer
Ann. Onc., May 1, 2009; 20(5): 879 - 884.
[Abstract] [Full Text] [PDF]

Home page
 Exp. Biol. Med.Home page
A. P. Araujo, R. Ribeiro, D. Pereira, D. Pinto, B. Sousa, R. Catarino, and R. Medeiros
Ovarian Cancer and Genetic Susceptibility: Association of A61G Polymorphism in the EGF Gene
Experimental Biology and Medicine, March 1, 2009; 234(3): 241 - 245.
[Abstract] [Full Text] [PDF]

Home page
 Neuro Oncol DukeHome page
M. Linnebank, A. Semmler, S. Moskau, Y. Smulders, H. Blom, and M. Simon
The methylenetetrahydrofolate reductase (MTHFR) variant c.677C>T (A222V) influences overall survival of patients with glioblastoma multiforme
Neuro-oncol, August 1, 2008; 10(4): 548 - 552.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
A. L. Teixeira, R. Ribeiro, D. Cardoso, D. Pinto, F. Lobo, A. Fraga, F. Pina, F. Calais-da-Silva, and R. Medeiros
Genetic Polymorphism in EGF Is Associated with Prostate Cancer Aggressiveness and Progression-Free Interval in Androgen Blockade-Treated Patients
Clin. Cancer Res., June 1, 2008; 14(11): 3367 - 3371.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
M. Lanuti, G. Liu, J. M. Goodwin, R. Zhai, B. C. Fuchs, K. Asomaning, L. Su, N. S. Nishioka, K. K. Tanabe, and D. C. Christiani
A Functional Epidermal Growth Factor (EGF) Polymorphism, EGF Serum Levels, and Esophageal Adenocarcinoma Risk and Outcome
Clin. Cancer Res., May 15, 2008; 14(10): 3216 - 3222.
[Abstract] [Full Text] [PDF]

Home page
 JAMAHome page
K. K. Tanabe, A. Lemoine, D. M. Finkelstein, H. Kawasaki, T. Fujii, R. T. Chung, G. Y. Lauwers, Y. Kulu, A. Muzikansky, D. Kuruppu, et al.
Epidermal Growth Factor Gene Functional Polymorphism and the Risk of Hepatocellular Carcinoma in Patients With Cirrhosis
JAMA, January 2, 2008; 299(1): 53 - 60.
[Abstract] [Full Text] [PDF]

Home page
 Mol Hum ReprodHome page
V.H.W. Dissanayake, C. Tower, A. Broderick, L.J. Stocker, H.R. Seneviratne, R.W. Jayasekara, N. Kalsheker, F.B. Pipkin, and L. Morgan
Polymorphism in the epidermal growth factor gene is associated with birthweight in Sinhalese and white Western Europeans
Mol. Hum. Reprod., June 1, 2007; 13(6): 425 - 429.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
B. M. Costa, P. Ferreira, S. Costa, P. Canedo, P. Oliveira, A. Silva, F. Pardal, G. Suriano, J. C. Machado, J. M. Lopes, et al.
Association between Functional EGF+61 Polymorphism and Glioma Risk
Clin. Cancer Res., May 1, 2007; 13(9): 2621 - 2626.
[Abstract] [Full Text] [PDF]

Home page
 The OncologistHome page
A. Araujo, R. Ribeiro, I. Azevedo, A. Coelho, M. Soares, B. Sousa, D. Pinto, C. Lopes, R. Medeiros, and G. V. Scagliotti
Genetic Polymorphisms of the Epidermal Growth Factor and Related Receptor in Non-Small Cell Lung Cancer--A Review of the Literature
Oncologist, February 1, 2007; 12(2): 201 - 210.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
M. Wrensch, A. McMillan, J. Wiencke, J. Wiemels, K. Kelsey, J. Patoka, H. Jones, V. Carlton, R. Miike, J. Sison, et al.
Nonsynonymous Coding Single-Nucleotide Polymorphisms Spanning the Genome in Relation to Glioblastoma Survival and Age at Diagnosis
Clin. Cancer Res., January 1, 2007; 13(1): 197 - 205.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
C. Carpentier, F. Laigle-Donadey, Y. Marie, N. Auger, A. Benouaich-Amiel, J. Lejeune, G. Kaloshi, J. -Y. Delattre, J. Thillet, and M. Sanson
Polymorphism in Sp1 recognition site of the EGF receptor gene promoter and risk of glioblastoma
Neurology, September 12, 2006; 67(5): 872 - 874.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
M. Wrensch, J. K. Wiencke, J. Wiemels, R. Miike, J. Patoka, M. Moghadassi, A. McMillan, K. T. Kelsey, K. Aldape, K. R. Lamborn, et al.
Serum IgE, Tumor Epidermal Growth Factor Receptor Expression, and Inherited Polymorphisms Associated with Glioma Survival.
Cancer Res., April 15, 2006; 66(8): 4531 - 4541.
[Abstract] [Full Text] [PDF]

Home page
 Ann OncolHome page
R. de las Penas, M. Sanchez-Ronco, V. Alberola, M. Taron, C. Camps, R. Garcia-Carbonero, B. Massuti, C. Queralt, M. Botia, R. Garcia-Gomez, et al.
Polymorphisms in DNA repair genes modulate survival in cisplatin/gemcitabine-treated non-small-cell lung cancer patients
Ann. Onc., April 1, 2006; 17(4): 668 - 675.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
C.-T. Kuan, K. Wakiya, J. M. Dowell, J. E. Herndon II, D. A. Reardon, M. W. Graner, G. J. Riggins, C. J. Wikstrand, and D. D. Bigner
Glycoprotein nonmetastatic melanoma protein B, a potential molecular therapeutic target in patients with glioblastoma multiforme.
Clin. Cancer Res., April 1, 2006; 12(7): 1970 - 1982.
[Abstract] [Full Text] [PDF]

Home page
 Neuro Oncol DukeHome page
M. Wrensch, T. Rice, R. Miike, A. McMillan, K. R. Lamborn, K. Aldape, and M. D. Prados
Diagnostic, treatment, and demographic factors influencing survival in a population-based study of adult glioma patients in the San Francisco Bay Area
Neuro-oncol, January 1, 2006; 8(1): 12 - 26.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
Y. Goto, T. Ando, H. Goto, and N. Hamajima
No Association Between EGF Gene Polymorphism and Gastric Cancer
Cancer Epidemiol. Biomarkers Prev., October 1, 2005; 14(10): 2454 - 2456.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
J. Tang, W. Shao, M. T. Dorak, Y. Li, R. Miike, E. Lobashevsky, J. K. Wiencke, M. Wrensch, R. A. Kaslow, and C. S. Cobbs
Positive and Negative Associations of Human Leukocyte Antigen Variants with the Onset and Prognosis of Adult Glioblastoma Multiforme
Cancer Epidemiol. Biomarkers Prev., August 1, 2005; 14(8): 2040 - 2044.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2004 by the American Association for Cancer Research.